跳至主要内容
临床试验/NCT07615309
NCT07615309Enrolling By Invitation不适用

Clinical Efficacy and Prognostic Analysis of Omadacycline in the Treatment of Mycobacterium Abscessus Pulmonary Disease.

Beijing Chest Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年1月1日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
200
试验地点
1

研究概览

简要总结

The objective of this clinical trial is to evaluate the correlation between clinical efficacy and safety of omadacycline in the treatment of Mycobacterium abscessus infection through retrospective cohort studies. The main questions it aims to answer include: Clinical efficacy of omadacycline in populations stratified by clinical characteristics including age, gender, comorbid immune diseases, albumin level, white blood cell count and pulmonary cavity manifestations on CT.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Mycobacterium abscessus pulmonary disease confirmed by bacteriological culture or molecular biology testing;
  • Age 18 years or older at the time of diagnosis;
  • Complete clinical records available for review;
  • Treatment duration of at least 1 month.

排除标准

  • Co-infection with other non-tuberculous mycobacterial species;
  • Treatment duration less than 1 month;
  • Missing key clinical data required for outcome assessment.

研究者

发起方
Beijing Chest Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nie WenJuan

chief physician

Beijing Chest Hospital

研究点 (1)

Loading locations...

相似试验